
Michael Walsh MD FAAP, FACMG
Cancer Genetics/Cancer Risk Assessment, Pediatric Hematologic Oncology
Associate Member, Memorial Sloan Kettering Cancer Center Associate Professor, Weill Cornell Medical College Associate Program Director, Medical Genetics Fellowship Program
8900 N Kendall DriveMiami, FL 33186
Overview of Dr. Walsh
Dr. Michael Walsh, based in New York, NY, is an esteemed specialist in Pediatric Hematology & Oncology with subspecialties in Cancer Genetics/Cancer Risk Assessment and Pediatric Hematologic Oncology. He completed his medical education at University College of Dublin and holds a BA in Economics from Boston College. His postgraduate training included an internship and residency in Pediatrics and Medical Genetics at Johns Hopkins University, followed by a fellowship in Pediatric Hematology/Oncology at the University of Tennessee. Dr. Walsh serves as an Associate Professor at Memorial Sloan Kettering Cancer Center. His research interests are reflected in his publications on topics such as tumor genetics and hereditary cancer risks. He is actively involved in clinical trials focused on discovering genetic markers for hereditary cancer risks. Throughout his career, he has been recognized with several awards, including the Young Investigator Award from the American Society of Pediatric Hematology Oncology and the Rising Stars acknowledgement from Super Doctors.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2011 - 2014
John Hopkins UniversityResidency, Medical Genetics and Genomics/Pediatrics, 2007 - 2011
Johns Hopkins UniversityInternship, Pediatrics, 2006 - 2007
University College of Dublin National Univ SOMClass of 2005
Boston CollegeBA, Economics, 1995 - 1999
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2014 - 2026
NJ State Medical License 2023 - 2025
CT State Medical License 2023 - 2024
TN State Medical License 2012 - 2016
MD State Medical License 2010 - 2011
American Board of Pediatrics Pediatrics
American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Rising Stars, Super Doctors Superdoctors.com, 2021
- Young Investigator Award American Society of Pediatric Hematology Oncology (ASPHO), 2016
- Margaret Ellen Nielsen Fellowship Award McKusick Nathan Institute of Genetic Medicine, Johns Hopkins, 2009
Clinical Trials
- Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer Start of enrollment: 2019 Apr 17
Publications & Presentations
PubMed
- Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer Picarsic, David Abramson, Veronica Rotemberg
Nature Medicine. 2026-09-01 - The WHO Classification of Genetic Tumour Syndromes: Considerations for Genetics.Ian A Cree, Mark J Arends, Joseph D Khoury, Erika R E Denton, Anthony J Gill
Clinical Genetics. 2026-09-01 - The WHO Classification of Genetic Tumour Syndromes: Considerations for histopathology.Ian A Cree, Mark J Arends, Joseph D Khoury, Erika Re Denton, Anthony J Gill
Histopathology. 2026-06-01
Journal Articles
- Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumorsElise M. Fiala, Gowtham Jayakumaran, Audrey Mauguen, Jennifer A. Kennedy, Nancy Bouvier, Yelena Kemel, Megan Harlan Fleischut, Anna Maio, Erin E. Salo-Mullen, Margaret..., Nature Cancer, 2/15/2021
- Pathogenic Loss-of-Function Germline TERT Mutations in Patients With Solid TumorsMichael F. Walsh, MD; Rosalba Sacca, PhD; Temima Wildman, MS; Kimberly Amoroso, MS; Jennifer Kennedy, MS; Liying Zhang, MD, PhD; Ozge Birsoy, PhD; Diana Mandelker, MD,..., JCO PO, 10/23/2019
Books/Book Chapters
Press Mentions
JHAH and TruDoc Healthcare Partner to Offer Hospital at Home Services in Saudi ArabiaSeptember 26th, 2024
Michael F. Walsh, M.D., Joins Baptist Health Herbert Wertheim Cancer Institute as Deputy Director and Chief of PreventionOctober 15th, 2026
Michael F. Walsh, MD, Joins Baptist Health Herbert Wertheim Cancer Institute as Deputy Director and Chief of PreventionNovember 2nd, 2026
Grant Support
- Determining the Heritable Basis for Acute Lymphoblastic LeukemiaV Foundation for Cancer Research2015–Present
Committees
- Representative/Liason to Commision on Cancer, American Collge of Medical Genetics 2020 - Present
- Chair, ClinGen Somatic/Germline Variant Curation 2016 - Present
Research History
- Post Doc Fellow, Downing LabPediatric Cancer Genome Project, St. Jude Children's Research Hospital2011 - 2014
- Genetic Fellow, Armanios LabMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins2009 - 2011
Professional Memberships
- Fellow
- Member
- American College of Medical GeneticsFellow
External Links
- MSKCC https://www.mskcc.org/cancer-care/doctors/michael-walsh
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: